Novartis was bringing to market an exciting breakthrough treatment that specifically targeted two debilitating diseases, Ankylosing Spondylitis and Psoriatic Arthritis. Our brief was to produce an email series and microsite to excite and inform a global marketing team.
We aimed much higher, proposing an app for an initiative we named REACH (Rheumatology Experience A Change). The app connected teams in more than 20 countries worldwide, turning them into a close-knit community that could share information, insights and success all from their smart phones. It effectively turned a short-term email based brief into a long-lasting solution that is still in use after more than two years.